Company · CIK 0001800315 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Damora Therapeutics, Inc. · DMRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 SForm 4 → | Jul 7, 8:00 pm EDT | Garrett WinslowGeneral Counsel | 245 | $29.98 | $7,345 | 2,289 | −9.67% | |
| Jul 3, 2026 MForm 4 → | Jul 7, 8:00 pm EDT | Garrett WinslowGeneral Counsel | 680 | — | — | 2,534 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 AForm 4 → | Aug 13, 5:00 pm EDT | Andrew ChengDirector | 30,350 | — | — | 30,350 | — | |
| Jul 3, 2026 MForm 4 → | Jul 7, 8:00 pm EDT | Garrett WinslowGeneral Counsel | 680 | — | — | 640 | — |